Corrigendum

Date: 10th August, 2026 Listing Department, National Stock Exchange of India Limited Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 NSE Symbol: BALAXI Subject: Corrigendum to the Notice of 83rd Annual General Meeting (‘AGM’) Dear Sir / Madam, This is in reference to our announcement dated 31st July, 2026 with National Stock Exchange of India Limited (“the Exchange”) regarding the Notice convening the 83rd AGM of the Company scheduled to be held on Monday, 24th August, 2026 at 11:00 A.M. (IST) through Video Conferencing / Other Audio Visual Means (‘VC/OAVM’), and submission of Annual Report for financial year 2025-26. The Exchange and the Members are hereby informed that due to typographical error, the Cut-off Date for determining the eligibility of Members to cast their vote through remote e-Voting and voting during the AGM was inadvertently mentioned as 14th August, 2026 in the Notice of the 83rd AGM. The Exchange and the Members are requested to take note that the Company has issued a Corrigendum dated 10th August, 2026 in continuation of the Notice of the 83rd Annual General Meeting which is enclosed herewith as Annexure A to correct and clarify that “14th August, 2026” or “August 14, 2026” shall be read as “17th August, 2026” at all places wherever appearing in the Notice of the 83rd AGM. The Corrigendum to the Notice of 83rd AGM is being sent electronically to the shareholders who have registered their email IDs with the Company or Depository Participant(s) or Registrar and Share Transfer Agent of the Company. Further, a letter providing the web-link to access the said Corrigendum is being sent to those Members who have not registered their e-mail address. The Corrigendum is also available on the website of the Company at the below mentioned weblink: https://balaxipharma.in/assets/images/articles/Balaxi_Corrigendum_to_the_83rd_AGM_Noti ce.pdf All other contents, terms and conditions of the Notice of the 83rd AGM shall remain unchanged. The Corrigendum forms an integral part of the 83rd AGM Notice dated 28th May, 2026 and the Annual Report of the Company for the financial year 2025-26 which were circulated to shareholders on 31st July, 2026. This is for your information and record. Thanking You. Yours faithfully, For Balaxi Pharmaceuticals Limited Aman Purohit (Company Secretary & Compliance Officer) ICSI Membership No.: A59345 (Encl: As above) ANNEXURE – A CORRIGENDUM TO THE NOTICE OF THE 83RD ANNUAL GENERAL MEETING This corrigendum is being issued in continuation of the Notice convening the 83rd Annual General Meeting (“AGM”) of the Members of Balaxi Pharmaceuticals Limited (“the Company”) to be held on Monday, 24th August, 2026 at 11:00 A.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). Members are hereby informed that due to a typographical error, the Cut-off Date for determining the eligibility of Members to cast their vote through remote e-Voting and voting during the AGM was inadvertently mentioned as 14th August, 2026 in the Notice of the AGM. Members are requested to take note that “14th August, 2026” or “August 14, 2026” shall be read as “17th August, 2026” at all places wherever appearing in the Notice of the 83rd AGM. Accordingly, members are requested to take note of the following: 1. 17th August, 2026 shall be considered as the Cut-off Date for determining the eligibility of Members to cast their votes through remote e-Voting and voting during the AGM. The Members, whose names appear in the Register of Members / Beneficial Owners as on the record date (cut-off date) i.e. August 17, 2026, may cast their vote electronically. 2. Any person, who acquires shares of the Company and becomes a member of the Company after dispatch of the Notice, and holds shares as of the cut-off date i.e., 17th August, 2026, may obtain the login ID and password by sending an email to evoting@nsdl.com with one’s DP ID and Client ID. 3. The voting rights of members shall be in proportion to their shares of the paid-up equity share capital of the Company as on 17th August, 2026. All other contents, terms and conditions of the Notice of the 83rd AGM shall remain unchanged. This Corrigendum forms an integral part of the 83rd AGM Notice dated 28th May, 2026 and the Annual Report of the Company for the financial year 2025-26, circulated to shareholders on 31st July, 2026. By Order of the Board of Directors For Balaxi Pharmaceuticals Limited Aman Purohit Company Secretary and Compliance Officer ICSI Membership No.: A59345 Date: 10th August, 2026 Place: Hyderabad